表紙:放射線性直腸炎の世界市場 (2020-2030年):産業分析・市場動向・市場シェア・市場成長予測
市場調査レポート
商品コード
997267

放射線性直腸炎の世界市場 (2020-2030年):産業分析・市場動向・市場シェア・市場成長予測

Radiation Proctitis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

出版日: | 発行: Transparency Market Research | ページ情報: 英文 153 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.77円
放射線性直腸炎の世界市場 (2020-2030年):産業分析・市場動向・市場シェア・市場成長予測
出版日: 2021年02月24日
発行: Transparency Market Research
ページ情報: 英文 153 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の放射線性直腸炎の市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、市場規模の推移・予測、適応症・治療法・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 序文

第2章 前提因子・調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 市場分析・予測
  • ポーターのファイブフォース分析

第5章 市場の展望

  • 尿失禁の有病率:地域別
  • 主要な産業イベント
  • 規制シナリオ
  • 技術の進歩
  • トップ企業の主な成功因子

第6章 市場分析・予測:適応症別

  • 急性放射線直腸炎
  • 慢性放射線直腸炎
  • 市場の魅力

第7章 市場分析・予測:治療法別

  • 経口療法
  • アブレーション施術
  • 高圧酸素療法
  • ホルマリン
  • 手術
  • 市場の魅力

第8章 市場分析・予測:地域別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ
  • 市場の魅力

第9章 北米市場の分析・予測

  • 市場分析・予測:適応症別
  • 市場分析・予測:治療法別
  • 市場分析・予測:国・地域別
  • 市場の魅力

第10章 欧州市場の分析・予測

第11章 アジア太平洋市場の分析・予測

第12章 ラテンアメリカ市場の分析・予測

第13章 中東・アフリカ市場の分析・予測

第14章 競合情勢

  • 市場シェア分析
  • 企業プロファイル
    • Allergan plc
    • Teva Pharmaceutical Industries Ltd.
    • Amneal Pharmaceuticals, Inc.
    • Pfizer, Inc.
    • Mylan, Inc., (Viatris)
    • Sanofi
    • Johnson & Johnson (Johnson & Johnson Consumer, Inc.)
    • Sun Pharmaceutical Industries Ltd.
    • Environmental Tectonics Corporation
    • Sechrist Industries, Inc.
図表

List of Tables

  • Table 01: Radiation Proctitis: Clinical Trial Pipeline Analysis (1/2)
  • Table 02: Radiation Proctitis: Clinical Trial Pipeline Analysis (2/2)
  • Table 03: Estimated Number of Patients with Radiation Proctitis, by Key indications, by Key Countries 2020 (1/2)
  • Table 04: Estimated Number of Patients with Radiation Proctitis, by Key indications, by Key Countries 2020 (2/2)
  • Table 05: Global Radiation Proctitis Market Value (US$ Mn) Forecast, by Indication, 2018-2030
  • Table 06: Global Radiation Proctitis Market Value (US$ Mn) Forecast, by Therapy, 2018-2030
  • Table 07: Global Radiation Proctitis Market Value (US$ Mn) Forecast, by Oral Therapy, 2018-2030
  • Table 08: Global Radiation Proctitis Market Value (US$ Mn) Forecast, by Region, 2018-2030
  • Table 09: North America Radiation Proctitis Market Value (US$ Mn) Forecast, by Country, 2018-2030
  • Table 10: North America Radiation Proctitis Market Value (US$ Mn) Forecast, by Indication, 2018-2030
  • Table 11: North America Radiation Proctitis Market Value (US$ Mn) Forecast, by Therapy, 2018-2030
  • Table 12: North America Radiation Proctitis Market Value (US$ Mn) Forecast, by Oral Therapy, 2018-2030
  • Table 13: Europe Radiation Proctitis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 14: Europe Radiation Proctitis Market Value (US$ Mn) Forecast, by Indication, 2018-2030
  • Table 15: Europe Radiation Proctitis Market Value (US$ Mn) Forecast, by Therapy, 2018-2030
  • Table 16: Europe Radiation Proctitis Market Value (US$ Mn) Forecast, by Oral Therapy, 2018-2030
  • Table 17: Asia Pacific Radiation Proctitis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 18: Asia Pacific Radiation Proctitis Market Value (US$ Mn) Forecast, by Indication, 2018-2030
  • Table 19: Asia Pacific Radiation Proctitis Market Value (US$ Mn) Forecast, by Therapy, 2018-2030
  • Table 20: Asia Pacific Radiation Proctitis Market Value (US$ Mn) Forecast, by Oral Therapy, 2018-2030
  • Table 21: Latin America Radiation Proctitis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 22: Latin America Radiation Proctitis Market Value (US$ Mn) Forecast, by Indication, 2018-2030
  • Table 23: Latin America Radiation Proctitis Market Value (US$ Mn) Forecast, by Therapy, 2018-2030
  • Table 24: Latin America Radiation Proctitis Market Value (US$ Mn) Forecast, by Oral Therapy, 2018-2030
  • Table 25: Middle East & Africa Radiation Proctitis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 26: Middle East & Africa Radiation Proctitis Market Value (US$ Mn) Forecast, by Indication, 2018-2030
  • Table 27: Middle East & Africa Radiation Proctitis Market Value (US$ Mn) Forecast, by Therapy, 2018-2030
  • Table 28: Middle East & Africa Radiation Proctitis Market Value (US$ Mn) Forecast, by Oral Therapy, 2018-2030

List of Figures

  • Figure 01: Global Radiation Proctitis Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 02: Global Radiation Proctitis Market Value Share, by Indication, 2019
  • Figure 03: Global Radiation Proctitis Market Value Share, by Therapy, 2019
  • Figure 04: Global Radiation Proctitis Market Value Share, by Region, 2019
  • Figure 05: Global Radiation Proctitis Market Value Share Analysis, by Indication, 2019 and 2030
  • Figure 06: Global Radiation Proctitis Market Attractiveness Analysis, by Indication, 2020-2030
  • Figure 07: Global Radiation Proctitis Market Value (US$ Mn), by Acute Radiation Proctitis, 2018-2030
  • Figure 08: Global Radiation Proctitis Market Value (US$ Mn), by Chronic Radiation Proctitis, 2018-2030
  • Figure 09: Global Radiation Proctitis Market Value Share Analysis, by Therapy, 2019 and 2030
  • Figure 10: Global Radiation Proctitis Market Attractiveness Analysis, by Therapy, 2020-2030
  • Figure 11: Global Radiation Proctitis Market Value (US$ Mn), by Oral Therapy, 2018-2030
  • Figure 12: Global Radiation Proctitis Market Value (US$ Mn), by Ablative Procedures, 2018-2030
  • Figure 13: Global Radiation Proctitis Market Value (US$ Mn), by Hyperbaric Oxygen Therapy, 2018-2030
  • Figure 14: Global Radiation Proctitis Market Value (US$ Mn), by Formalin, 2018-2030
  • Figure 15: Global Radiation Proctitis Market Value (US$ Mn), by Surgery, 2018-2030
  • Figure 16: Global Radiation Proctitis Market Value Share Analysis, by Region, 2019 and 2030
  • Figure 17: Global Radiation Proctitis Market Attractiveness Analysis, by Region, 2020-2030
  • Figure 18: North America Radiation Proctitis Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 19: North America Radiation Proctitis Market Value Share Analysis, by Country, 2019 and 2030
  • Figure 20: North America Radiation Proctitis Market Attractiveness Analysis, by Country, 2020-2030
  • Figure 21: North America Radiation Proctitis Market Value Share Analysis, by Indication, 2019 and 2030
  • Figure 22: North America Radiation Proctitis Market Attractiveness Analysis, by Indication, 2020-2030
  • Figure 23: North America Radiation Proctitis Market Value Share Analysis, by Therapy, 2019 and 2030
  • Figure 24: North America Radiation Proctitis Market Attractiveness Analysis, by Therapy, 2020-2030
  • Figure 25: Europe Radiation Proctitis Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 26: Europe Radiation Proctitis Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 27: Europe Radiation Proctitis Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 28: Europe Radiation Proctitis Market Value Share Analysis, by Indication, 2019 and 2030
  • Figure 29: Europe Radiation Proctitis Market Attractiveness Analysis, by Indication, 2020-2030
  • Figure 30: Europe Radiation Proctitis Market Value Share Analysis, by Therapy, 2019 and 2030
  • Figure 31: Europe Radiation Proctitis Market Attractiveness Analysis, by Therapy, 2020-2030
  • Figure 32: Asia Pacific Radiation Proctitis Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 33: Asia Pacific Radiation Proctitis Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 34: Asia Pacific Radiation Proctitis Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 35: Asia Pacific Radiation Proctitis Market Value Share Analysis, by Indication, 2019 and 2030
  • Figure 36: Asia Pacific Radiation Proctitis Market Attractiveness Analysis, by Indication, 2020-2030
  • Figure 37: Asia Pacific Radiation Proctitis Market Value Share Analysis, by Therapy, 2019 and 2030
  • Figure 38: Asia Pacific Radiation Proctitis Market Attractiveness Analysis, by Therapy, 2020-2030
  • Figure 39: Latin America Radiation Proctitis Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 40: Latin America Radiation Proctitis Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 41: Latin America Radiation Proctitis Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 42: Latin America Radiation Proctitis Market Value Share Analysis, by Indication, 2019 and 2030
  • Figure 43: Latin America Radiation Proctitis Market Attractiveness Analysis, by Indication, 2020-2030
  • Figure 44: Latin America Radiation Proctitis Market Value Share Analysis, by Therapy, 2019 and 2030
  • Figure 45: Latin America Radiation Proctitis Market Attractiveness Analysis, by Therapy, 2020-2030
  • Figure 46: Middle East & Africa Radiation Proctitis Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 47: Middle East & Africa Radiation Proctitis Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 48: Middle East & Africa Radiation Proctitis Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 49: Middle East & Africa Radiation Proctitis Market Value Share Analysis, by Indication, 2019 and 2030
  • Figure 50: Middle East & Africa Radiation Proctitis Market Attractiveness Analysis, by Indication, 2020-2030
  • Figure 51: Middle East & Africa Radiation Proctitis Market Value Share Analysis, by Therapy, 2019 and 2030
  • Figure 52: Middle East & Africa Radiation Proctitis Market Attractiveness Analysis, by Therapy, 2020-2030
目次
Product Code: TMRGL81551

Title:
Radiation Proctitis Market (Indication: Acute Radiation Proctitis and Chronic Radiation Proctitis; and Therapy: Oral Therapy, Ablative Procedures, Hyperbaric Oxygen Therapy,Formalin, and Surgery) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030.

Scope of the Report

TMR's report on the global radiation proctitis market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global radiation proctitis market for the period 2018 - 2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global radiation proctitis market for the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players' Indication literature, annual reports, press releases, and relevant documents to understand the global radiation proctitis market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of top-down and bottom-up approaches to study various phenomena in the global radiation proctitis market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global radiation proctitis market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global radiation proctitis market. The next section of the global radiation proctitis market report highlights the USPs, which include epidemiology analysis, regulatory scenario, key industry events, technological advancements, and key success factors of top players operating in the global radiation proctitis market.

The report also delves into the competition landscape of the global radiation proctitis market. Key players operating in the global radiation proctitis market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global radiation proctitis market profiled in this report.

Key Questions Answered:

  • What are the major drivers, restraints, and opportunities in the market?
  • What are the revenue share projections of key segments of the global radiation proctitis market during the forecast period?
  • Which segment is likely to lead the global radiation proctitis market in terms of revenue by 2030?
  • How mergers & acquisitions among players are widening the scope for the global radiation proctitis market?
  • What is the market position of different companies operating in the global radiation proctitis market?

Research Objectives and Research Approach

The comprehensive report on the global radiation proctitis market begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind the study and healthcare compliances laid down by accredited agencies in the purview of research in the global radiation proctitis market. It is followed by market introduction, market dynamics, and an overview of the global radiation proctitis market, which includes TMR analysis of market drivers, restraints, and trends affecting the growth of the global radiation proctitis market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the global radiation proctitis market. The next section of the global radiation proctitis market report highlights the USPs, which include regulatory scenario, epidemiology analysis, technological advancements, and key success factors of top players in the global market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into smaller sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global radiation proctitis market in terms of indication, therapy, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investments in the radiation proctitis market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Radiation Proctitis market

4. Market Overview

  • 4.1. Introduction
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Radiation Proctitis Market Analysis and Forecast, 2018-2030
    • 4.4.1. Market Revenue Projections (US$ Mn)
  • 4.5. Porter's Five Force Analysis

5. Market Outlook

  • 5.1. Prevalence of Urinary Incontinence, by Region
  • 5.2. Key Industry Events
  • 5.3. Regulatory Scenario
  • 5.4. Technological Advancements
  • 5.5. Key Success Factors of Top Players

6. Global Radiation Proctitis Market Value (US$ Mn) Forecast, by Indication

  • 6.1. Introduction & Definition
  • 6.2. Global Radiation Proctitis Market Value Forecast, by Indication, 2018-2030
    • 6.2.1. Acute Radiation Proctitis
    • 6.2.2. Chronic Radiation Proctitis
  • 6.3. Global Radiation Proctitis Market Attractiveness Analysis, by Indication

7. Global Radiation Proctitis Market Value (US$ Mn) Forecast, by Therapy

  • 7.1. Introduction & Definition
  • 7.2. Global Radiation Proctitis Market Value Forecast, by Therapy, 2018-2030
    • 7.2.1. Oral Therapy
      • 7.2.1.1. Antidiarrheals
      • 7.2.1.2. Anti-inflammatory Agents
      • 7.2.1.3. Others
    • 7.2.2. Ablative Procedures
    • 7.2.3. Hyperbaric Oxygen Therapy
    • 7.2.4. Formalin
    • 7.2.5. Surgery

8. Global Radiation Proctitis Market Value (US$ Mn) Forecast, by Region

  • 8.1. Introduction
  • 8.2. Radiation Proctitis Market Value Forecast, by Region, 2018-2030
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Global Radiation Proctitis Market Attractiveness Analysis, by Region

9. North America Radiation Proctitis Market Analysis and Forecast

  • 9.1. Introduction
  • 9.2. North America Radiation Proctitis Market Value Forecast, by Indication, 2018-2030
    • 9.2.1. Acute Radiation Proctitis
    • 9.2.2. Chronic Radiation Proctitis
  • 9.3. North America Radiation Proctitis Market Value Forecast, by Therapy, 2018-2030
    • 9.3.1. Oral Therapy
      • 9.3.1.1. Antidiarrheals
      • 9.3.1.2. Anti-inflammatory Agents
      • 9.3.1.3. Others
    • 9.3.2. Ablative Procedures
    • 9.3.3. Hyperbaric Oxygen Therapy
    • 9.3.4. Formalin
    • 9.3.5. Surgery
  • 9.4. North America Radiation Proctitis Market Value Forecast, by Country/Sub-region, 2018-2030
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. North America Radiation Proctitis Market Attractiveness Analysis
    • 9.5.1. By Indication
    • 9.5.2. By Therapy
    • 9.5.3. By Country/Sub-region

10. Europe Radiation Proctitis Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Europe Radiation Proctitis Market Value Forecast, by Indication, 2018-2030
    • 10.2.1. Acute Radiation Proctitis
    • 10.2.2. Chronic Radiation Proctitis
  • 10.3. Europe Radiation Proctitis Market Value Forecast, by Therapy, 2018-2030
    • 10.3.1. Oral Therapy
      • 10.3.1.1. Antidiarrheals
      • 10.3.1.2. Anti-inflammatory Agents
      • 10.3.1.3. Others
    • 10.3.2. Ablative Procedures
    • 10.3.3. Hyperbaric Oxygen Therapy
    • 10.3.4. Formalin
    • 10.3.5. Surgery
  • 10.4. Europe Radiation Proctitis Market Value Forecast, by Country/Sub-region, 2018-2030
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Spain
    • 10.4.5. Italy
    • 10.4.6. Rest of Europe
  • 10.5. Europe Radiation Proctitis Market Attractiveness Analysis
    • 10.5.1. By Indication
    • 10.5.2. By Therapy
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Radiation Proctitis Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Asia Pacific Radiation Proctitis Market Value Forecast, by Indication, 2018-2030
    • 11.2.1. Acute Radiation Proctitis
    • 11.2.2. Chronic Radiation Proctitis
  • 11.3. Asia Pacific Radiation Proctitis Market Value Forecast, by Therapy, 2018-2030
    • 11.3.1. Oral Therapy
      • 11.3.1.1. Antidiarrheals
      • 11.3.1.2. Anti-inflammatory Agents
      • 11.3.1.3. Others
    • 11.3.2. Ablative Procedures
    • 11.3.3. Hyperbaric Oxygen Therapy
    • 11.3.4. Formalin
    • 11.3.5. Surgery
  • 11.4. Asia Pacific Radiation Proctitis Market Value Forecast, by Country/Sub-region, 2018-2030
    • 11.4.1. Japan
    • 11.4.2. China
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Asia Pacific Radiation Proctitis Market Attractiveness Analysis
    • 11.5.1. By Indication
    • 11.5.2. By Therapy
    • 11.5.3. By Country/Sub-region

12. Latin America Radiation Proctitis Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Latin America Radiation Proctitis Market Value Forecast, by Indication, 2018-2030
    • 12.2.1. Acute Radiation Proctitis
    • 12.2.2. Chronic Radiation Proctitis
  • 12.3. Latin America Radiation Proctitis Market Value Forecast, by Therapy, 2018-2030
    • 12.3.1. Oral Therapy
    • 12.3.2. Ablative Procedures
    • 12.3.3. Hyperbaric Oxygen Therapy
    • 12.3.4. Formalin
    • 12.3.5. Surgery
  • 12.4. Latin America Radiation Proctitis Market Value Forecast, by Country/Sub-region, 2018-2030
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Latin America Radiation Proctitis Market Attractiveness Analysis
    • 12.5.1. By Indication
    • 12.5.2. By Therapy
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Radiation Proctitis Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Middle East & Africa Radiation Proctitis Market Value Forecast, by Indication, 2018-2030
    • 13.2.1. Acute Radiation Proctitis
    • 13.2.2. Chronic Radiation Proctitis
  • 13.3. Middle East & Africa Radiation Proctitis Market Value Forecast, by Therapy, 2018-2030
    • 13.3.1. Oral Therapy
      • 13.3.1.1. Antidiarrheals
      • 13.3.1.2. Anti-inflammatory Agents
      • 13.3.1.3. Others
    • 13.3.2. Ablative Procedures
    • 13.3.3. Hyperbaric Oxygen Therapy
    • 13.3.4. Formalin
    • 13.3.5. Surgery
  • 13.4. Middle East & Africa Radiation Proctitis Market Value Forecast, by Country/Sub-region, 2018-2030
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Middle East & Africa Radiation Proctitis Market Attractiveness Analysis
    • 13.5.1. By Indication
    • 13.5.2. By Therapy
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Global Radiation Proctitis Market Share Analysis, by Company, 2019
  • 14.2. Company Profiles
    • 14.2.1. Allergan plc
      • 14.2.1.1. Company Description
      • 14.2.1.2. Business Overview
      • 14.2.1.3. Financial Overview
      • 14.2.1.4. Strategic Overview
      • 14.2.1.5. SWOT Analysis
    • 14.2.2. Teva Pharmaceutical Industries Ltd.
      • 14.2.2.1. Company Description
      • 14.2.2.2. Business Overview
      • 14.2.2.3. Financial Overview
      • 14.2.2.4. Strategic Overview
      • 14.2.2.5. SWOT Analysis
    • 14.2.3. Amneal Pharmaceuticals, Inc.
      • 14.2.3.1. Company Description
      • 14.2.3.2. Business Overview
      • 14.2.3.3. Financial Overview
      • 14.2.3.4. Strategic Overview
      • 14.2.3.5. SWOT Analysis
    • 14.2.4. Pfizer, Inc.
      • 14.2.4.1. Company Description
      • 14.2.4.2. Business Overview
      • 14.2.4.3. Financial Overview
      • 14.2.4.4. Strategic Overview
      • 14.2.4.5. SWOT Analysis
    • 14.2.5. Mylan, Inc., (Viatris)
      • 14.2.5.1. Company Description
      • 14.2.5.2. Business Overview
      • 14.2.5.3. Financial Overview
      • 14.2.5.4. Strategic Overview
      • 14.2.5.5. SWOT Analysis
    • 14.2.6. Sanofi
      • 14.2.6.1. Company Description
      • 14.2.6.2. Business Overview
      • 14.2.6.3. Financial Overview
      • 14.2.6.4. Strategic Overview
      • 14.2.6.5. SWOT Analysis
    • 14.2.7. Johnson & Johnson (Johnson & Johnson Consumer, Inc.)
      • 14.2.7.1. Company Description
      • 14.2.7.2. Business Overview
      • 14.2.7.3. Financial Overview
      • 14.2.7.4. Strategic Overview
      • 14.2.7.5. SWOT Analysis
    • 14.2.8. Sun Pharmaceutical Industries Ltd.
      • 14.2.8.1. Company Description
      • 14.2.8.2. Business Overview
      • 14.2.8.3. Financial Overview
      • 14.2.8.4. Strategic Overview
      • 14.2.8.5. SWOT Analysis
    • 14.2.9. Environmental Tectonics Corporation
      • 14.2.9.1. Company Description
      • 14.2.9.2. Business Overview
      • 14.2.9.3. Financial Overview
      • 14.2.9.4. Strategic Overview
      • 14.2.9.5. SWOT Analysis
    • 14.2.10. Sechrist Industries, Inc.
      • 14.2.10.1. Company Description
      • 14.2.10.2. Business Overview
      • 14.2.10.3. Financial Overview
      • 14.2.10.4. Strategic Overview
      • 14.2.10.5. SWOT Analysis